The critical role of WT1 in programmed cell death has been at times conflicting, depending on the cellular context, with differing impacts on the antiapoptotic gene family, BCL2 [60], suggesting that the role of WT1 as a tumor suppressor or oncogene could be a result of WT1 effects on BCL2 family members. The gene discussed is WT1; the disease is neoplasm.